Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q3 2016

Baupost Group

Portfolio at the end of Q3 2016, from the 13F filed November 14, 2016. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 17.3% $1.21B 27,842,957 $43.60 Q1 2014 Reduce 7%
Viasat VSAT · history 12.2% $860.9M 11,533,137 $74.65 Q2 2013 or earlier No change
Synchrony SYF · history 7.0% $491.8M 17,565,000 $28.00 Q3 2016 Buy
Allergan AGN · history 6.6% $461.1M 2,001,978 $230.31 Q1 2016 No change
Antero Resources AR · history 5.6% $390.9M 14,505,881 $26.95 Q3 2014 No change
PBF Energy PBF · history 5.1% $356.0M 15,724,175 $22.64 Q3 2013 Add 48%
Dell Technologies DELL · history 4.5% $318.0M 6,652,459 $47.80 Q3 2016 Buy
Twenty-First Century Fox FOXA · history 4.4% $308.7M 12,746,469 $24.22 Q3 2015 Add 66%
Theravance Biopharma TBPH · history 3.8% $266.4M 7,350,991 $36.24 Q2 2014 No change
PayPal PYPL · history 2.9% $204.8M 5,000,000 $40.97 Q3 2015 Reduce 12%
Twenty-First Century Fox FOX · history 2.6% $180.1M 7,278,100 $24.74 Q3 2015 No change
Innoviva INVA · history 2.3% $164.1M 14,931,483 $10.99 Q2 2013 or earlier Reduce 15%
Veritiv VRTV · history 2.2% $152.7M 3,044,385 $50.17 Q3 2014 No change
Keryx Biopharmaceuticals KERX · history 1.9% $137.0M 25,791,678 $5.31 Q1 2014 No change
NorthStar Asset Management NSAM · history 1.8% $128.2M 9,913,654 $12.93 Q3 2016 Buy
Olin OLN · history 1.8% $126.8M 6,181,302 $20.52 Q3 2015 Reduce 42%
VMware VMW · history 1.7% $117.6M 1,603,889 $73.35 Q1 2016 Reduce 29%
Atara Biotherapeutics ATRA · history 1.6% $114.6M 5,359,632 $21.39 Q4 2014 No change
Forward Pharma FWP · history 1.6% $112.7M 5,367,300 $20.99 Q4 2014 No change
Qurate Retail QVCA · history 1.4% $98.5M 2,469,533 $39.87 Q2 2016 No change
Colony Financial CLNY · history 1.2% $81.0M 4,445,936 $18.23 Q3 2016 Buy
ChipMOS IMOS · history 1.1% $74.3M 3,751,853 $19.80 Q2 2013 or earlier No change
NorthStar Realty Finance NRF · history 1.0% $72.4M 5,498,261 $13.17 Q3 2016 Buy
KLX KLXI · history 1.0% $70.4M 2,000,000 $35.20 Q1 2015 No change
Silver Run Acquisition SRAQ · history 0.8% $59.1M 3,750,000 $15.75 Q2 2016 No change
American International Group AIG.WS · warrants · history 0.8% $55.0M 2,594,317 $21.20 Q2 2013 or earlier Add 2%
Novagold Resources NG · history 0.8% $53.2M 9,500,000 $5.60 Q2 2013 or earlier No change
Atlanta Braves Holdings BATRK · history 0.7% $52.0M 2,994,010 $17.38 Q2 2016 No change
The ODP Corporation ODP · history 0.7% $46.4M 13,000,000 $3.57 Q3 2016 Buy
Cascadian Therapeutics CASC · history 0.6% $41.0M 25,000,000 $1.64 Q2 2016 No change
Innoviva INVA.CV · convertible notes · history 0.6% $40.5M 48,230,000 prn Q3 2014 No change
Conyers Park Acquisition CPAA · history 0.5% $37.1M 3,712,500 $10.00 Q3 2016 Buy
Paratek Pharmaceuticals PRTK · history 0.4% $26.6M 2,044,498 $13.01 Q4 2014 No change
Saban Capital Acquisition SCAC.U · units · history 0.3% $23.5M 2,326,500 $10.08 Q3 2016 Buy
Credit Acceptance CACC · history 0.3% $20.1M 100,000 $201.07 Q2 2016 No change
Sunrun RUN · history 0.3% $17.9M 2,848,082 $6.30 Q3 2015 No change
Kindred Biosciences KIN · history 0.2% $15.0M 3,011,584 $4.99 Q4 2013 No change
Atlanta Braves Holdings BATRA · history 0.2% $14.0M 800,000 $17.45 Q2 2016 No change
Orexigen Therapeutics OREX · history 0.1% $7.4M 2,226,839 $3.32 Q3 2015 Reduce 90%
Tobira Therapeutics TBRA · history 0.1% $6.4M 160,829 $39.74 Q3 2016 Buy
Trilogy Metals TMQ · history 0.1% $5.8M 10,600,758 $0.55 Q2 2013 or earlier No change
Citigroup C.WS · warrants · history 0.1% $5.4M 102,553,207 $0.05 Q2 2013 or earlier No change
Silver Run Acquisition SRAQ.WS · warrants · history 0.1% $5.3M 950,000 $5.55 Q2 2016 Reduce 24%
Conyers Park Acquisition CPAA.WS · warrants · history 0.0% $1.4M 1,237,500 $1.15 Q3 2016 Buy
44 positions100.0%$7.04B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2016, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Energy27.9%
Media & telecom20.1%
Health care19.8%
Financials & real estate16.8%
Technology7.2%
Industrials3.4%
Materials2.6%
Consumer discretionary2.1%

What changed from Q2 2016

← Q2 2016 Q4 2016 →